All News

A new study revealed that researchers have found a genetic test that could help doctors determine which patients with multiple myeloma are at “ultra high risk” of their cancer progressing aggressively in its early stages.

Why is this patient on oxybutynin if he does not have any problems with his bladder?

Individuals with type 2 diabetes (T2D) who also experience coronary artery disease (CAD) may need to be treated more aggressively than those with coronary artery disease who do not have diabetes.

The Vantage Label Printer provides reliable, simplified solutions for any pharmacy.

Patients should be selected for therapy based on the FDA approved companion diagnostic for a trastuzumab product.

The FDA has granted accelerated approval to pemigatinib (Pemazyre, Incyte Corporation) as the first treatment for adults with certain types of previously treated, advanced cholangiocarcinoma.

This approval is a part of the first Project Orbis partnership between the FDA, Health Sciences Authority, and Swissmedic.

The FDA granted Amneal Pharmaceuticals for a generic version of buprenorphine (Butrans) transdermal system as well as a Competitive Generic Therapy designation.

Many health care companies are taking the opportunity to deliver testing kits to local pharmacies to properly equip pharmacists with the right resources during the pandemic.

A new study found that alternative swab materials and commonly available saline are effective for COVID-19 testing, allowing patients to self-administer tests.

New research has found that hospitalized patients with COVID-19, diabetes, and/or uncontrolled hyperglycemia have significantly higher mortality rates.

The study involved measuring the levels and analyzing the expression patterns of more than 3000 proteins in a large number of brain and cerebrospinal fluid samples collected at multiple research centers across the United States.

Loss of smell and taste has been anecdotally linked to COVID-19 infections, according to a study that reported the first empirical findings that strongly associate sensory loss with coronavirus disease 2019.

Researchers have found that approximately 1% of children have an allergy to cow’s milk, but up to 14% of families believe their children may have the condition, pointing to official guidelines for detecting cow’s milk allergy as a possible cause for the overdiagnosis.

A protein, known as FOXO1, plays a critical role in heart damage resulting from treatment with the chemotherapy drug anthracycline.

Who was the physician that discovered the need for doctors to wash their hands before every examination?

Brooke Griffin, PharmD, BCACP, discusses the 21st Century PharmD and how students are responding to COVID-19.

N95 respirators can be decontaminated effectively and maintain functional integrity for up to 3 uses, according to a study by the National Institutes of Health (NIH).

Pharmacists are a rich resource, not only in the management of colorectal cancer, but in every aspect of health care.

The CDC's updated guidance for pharmacies during the COVID-19 pandemic is based on the most recent information regarding safety practices and precautions for the disease.

As demands for pharmacy services increase, including COVID-19 point-of-care testing, pharmacy technician roles must continue to evolve to fill gaps in care and shortages of labor capital.

A survey conducted between March 30 to April 6 by InsightRx found that implementing the new vancomycin guidelines into the pharmacy community is as important as the coronavirus disease 2019 (COVID-19) in the healthcare system.

The clinical practice update incorporates emerging evidence and available guidance for patients with IBD.

Today, we’re thanking Luke Morrison, MHA, operations manager at Gates Pharmacy in North Carolina.

Additionally, this treatment gradually reduced the need for prophylactic FVII use, suggesting an effective control of bleeding that leads to a sustained clinical benefit in patients who received the highest doses of AAV5-hFVIII-SQ.

Located in Chapel Hill, North Carolina, the organization hopes to raise $125 million to generate 5 new drugs with human safety and dosing data in 5 years to be ready for the next pandemic.

In a new study, researchers present their findings of a signaling pathway that could be used in patients with triple-negative breast cancer (TNBC) to enhance therapies in the future.

The mitomycin gel is an alkylating drug, inhibiting the transcription of DNA into RNA and stopping protein synthesis and taking away the cancer cell’s ability to multiply.